IQVIA Holdings, Inc.

IQV

$270.37

Name : IQVIA Holdings, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $44,502,900,736.00

EPSttm : 8.03

IQVIA Holdings, Inc.

$270.37

1.69%

$4.65

IQV — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.53

Margin Of Safety %

Put/Call OI Ratio

0.76

EPS Next Q Diff

0.9

EPS Last/This Y

5.06

EPS This/Next Y

1.49

Price

270

Target Price

278.53

Analyst Recom

1.5

Performance Q

41.12

Upside

-34.3%

Beta

1.18

Ticker: IQV

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-08-28	IQV	261.67	0.73	1.66	10797
2026-08-31	IQV	261.29	0.73	4.78	11010
2026-09-01	IQV	258.38	0.76	1.16	11241
2026-09-02	IQV	263.94	0.74	3.71	11340
2026-09-03	IQV	271.69	0.75	3.24	11446
2026-09-04	IQV	267.67	0.76	0.11	11594
2026-09-08	IQV	259.21	0.74	0.17	11737
2026-09-09	IQV	256.97	0.68	1.49	12568
2026-09-10	IQV	257.42	0.69	0.56	12682
2026-09-11	IQV	261.8	0.68	0.07	12710
2026-09-14	IQV	265.73	0.66	0.60	12970
2026-09-15	IQV	269.5	0.65	0.05	13493
2026-09-16	IQV	268.82	0.56	0.17	14928
2026-09-17	IQV	269.49	0.54	3.10	15332
2026-09-18	IQV	266.34	0.58	0.71	16063
2026-09-21	IQV	270.01	0.84	0.24	10610
2026-09-22	IQV	270.16	0.81	0.58	10844
2026-09-23	IQV	268.04	0.80	0.24	10942
2026-09-24	IQV	275.16	0.76	0.41	11667
2026-09-25	IQV	270.42	0.76	0.35	11774
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-08-28	IQV	260.55	9.1	74.2	12.97
2026-08-31	IQV	261.35	9.1	84.2	12.97
2026-09-01	IQV	258.35	9.1	67.1	12.97
2026-09-02	IQV	263.89	9.1	668.7	12.97
2026-09-03	IQV	270.33	9.1	676.0	12.97
2026-09-04	IQV	267.67	9.1	588.1	12.97
2026-09-08	IQV	259.20	9.1	549.1	12.97
2026-09-09	IQV	256.90	9.1	601.1	12.97
2026-09-10	IQV	257.35	9.1	624.2	12.97
2026-09-11	IQV	261.80	9.1	659.8	12.97
2026-09-14	IQV	265.60	9.1	653.6	12.97
2026-09-15	IQV	269.60	9.1	654.1	12.97
2026-09-16	IQV	269.60	9.1	654.1	12.97
2026-09-17	IQV	269.57	9.1	627.2	12.97
2026-09-18	IQV	266.50	9.1	596.4	12.97
2026-09-21	IQV	269.95	9.1	650.7	12.97
2026-09-22	IQV	270.10	9.1	622.8	12.97
2026-09-23	IQV	267.87	9.1	602.5	12.97
2026-09-24	IQV	275.17	9.1	682.2	12.97
2026-09-25	IQV	270.00	9.1	579.8	12.97
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-08-28	IQV	-6.75	-1.44	2.61
2026-08-31	IQV	-6.75	-1.59	2.61
2026-09-01	IQV	-6.75	-1.59	2.61
2026-09-02	IQV	-6.75	-1.59	2.61
2026-09-03	IQV	-6.75	-1.59	2.61
2026-09-04	IQV	-6.75	-1.59	2.61
2026-09-08	IQV	-6.89	-1.27	2.61
2026-09-09	IQV	-6.89	-1.27	2.61
2026-09-10	IQV	-6.89	-1.27	2.61
2026-09-11	IQV	-6.89	-1.27	2.32
2026-09-14	IQV	-6.89	-1.28	2.32
2026-09-15	IQV	-6.89	-1.28	2.32
2026-09-16	IQV	-6.89	-1.28	2.32
2026-09-17	IQV	-6.89	-1.28	2.32
2026-09-18	IQV	-6.89	-1.28	2.32
2026-09-21	IQV	-6.89	-1.52	2.32
2026-09-23	IQV	-6.89	-1.52	2.32
2026-09-24	IQV	-6.89	-1.52	2.32
2026-09-25	IQV	-6.89	-1.52	2.53
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

Last Quarter Act. EPS

2.75

Avg. EPS Est. Current Quarter

3.27

Avg. EPS Est. Next Quarter

3.65

Insider Transactions

-6.89

Institutional Transactions

-1.52

Beta

1.18

Average Sales Estimate Current Quarter

4362

Average Sales Estimate Next Quarter

4535

Fair Value

288.4

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.5

Max Drawdown 5-Year %

-51.5

Target Price

278.53

P/E

33.46

Forward P/E

18.7

PEG

1.76

P/S

2.61

P/B

7.19

P/Free Cash Flow

20.33

EPS

8.06

Average EPS Est. Cur. Y

12.97

EPS Next Y. (Est.)

14.46

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

8.09

Relative Volume

0.67

Return on Equity vs Sector %

-4

Return on Equity vs Industry %

10.8

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

579.8

◆ IQV Healthcare

$269.73

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

0/20

Pullback

10/25

Volume

9/15

Valuation

9/20

TP/AR

6/10

Options

4/10

RSI

59.8

Range 1M

72.9%

Sup Dist

0.4%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

13/30

Estimates

10/20

Inst/Vol

4/15

Options

8/10

EPS Yr

8.8%

EPS NY

11.2%

52W%

94.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +11.7% upside

Quality

11/30

Valuation

8/30

Growth

8/25

Stability

2/10

LT Trend

1/5

Upside

+11.7%

Quality

MoS

IQV — P/E HistoricalDiagnostics & Research

IQVIA Holdings, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 94000

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and associated implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with Kexing Biopharm Co., Ltd. for biosimilar development. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. is based in Durham, North Carolina.

IQV

Latest News

—

Caricamento notizie per IQV…

stock quote shares IQV – IQVIA Holdings Inc. Stock Price stock today

news today IQV – IQVIA Holdings Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch IQV – IQVIA Holdings Inc. yahoo finance google finance

stock history IQV – IQVIA Holdings Inc. invest stock market

stock prices IQV premarket after hours

ticker IQV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IQV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y